160 related articles for article (PubMed ID: 12173468)
21. The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders.
Suppiah V; Alloza I; Heggarty S; Goris A; Dubois B; Carton H; Vandenbroeck K
J Neuroimmunol; 2005 Jul; 164(1-2):148-53. PubMed ID: 15904974
[TBL] [Abstract][Full Text] [Related]
22. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism.
Bilińska M; Frydecka I; Noga L; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Pokryszko-Dragan A
Acta Neurol Scand; 2004 Jul; 110(1):67-71. PubMed ID: 15180809
[TBL] [Abstract][Full Text] [Related]
23. [Relationship of CTLA-4 exon 1 A49-->G polymorphism with sCTLA-4 and Th1/Th2 bias in idiopathic dilated cardiomyopathy].
Liu W; Li WM; Gao C; Wang XR; Li DM; Sun NL
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3221-4. PubMed ID: 16405845
[TBL] [Abstract][Full Text] [Related]
24. [Genetic predisposition to multiple sclerosis as a polygenic autoimmune disease].
Favorova OO; Favorov AV; Boĭko AN; Sudomoina MA; Andreevskiĭ TV; Alekseenkov AD; Kulakova OG; Gusev EI; Parmigiani G; Ochs MF
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):16-22. PubMed ID: 19894308
[TBL] [Abstract][Full Text] [Related]
25. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients.
Lorentzen AR; Celius EG; Ekstrøm PO; Wiencke K; Lie BA; Myhr KM; Ling V; Thorsby E; Vartdal F; Spurkland A; Harbo HF
J Neuroimmunol; 2005 Sep; 166(1-2):197-201. PubMed ID: 16005527
[TBL] [Abstract][Full Text] [Related]
26. Ctla4 and multiple sclerosis in the Italian population.
Malferrari G; Stella A; Monferini E; Saltini G; Proverbio MC; Grimaldi LM; Rossi-Bernardi L; Biunno I
Exp Mol Pathol; 2005 Feb; 78(1):55-7. PubMed ID: 15596061
[TBL] [Abstract][Full Text] [Related]
27. CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders.
Pavkovic M; Georgievski B; Cevreska L; Spiroski M; Efremov DG
Am J Hematol; 2003 Feb; 72(2):147-9. PubMed ID: 12555221
[TBL] [Abstract][Full Text] [Related]
28. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil.
Brum DG; Barreira AA; Louzada-Junior P; Mendes-Junior CT; Donadi EA
J Neuroimmunol; 2007 Sep; 189(1-2):118-24. PubMed ID: 17681614
[TBL] [Abstract][Full Text] [Related]
29. CTLA4 dimorphisms and the multiple sclerosis phenotype.
Masterman T; Ligers A; Zhang Z; Hellgren D; Salter H; Anvret M; Hillert J
J Neuroimmunol; 2002 Oct; 131(1-2):208-12. PubMed ID: 12458054
[TBL] [Abstract][Full Text] [Related]
30. No evidence of association of CTLA4 polymorphisms with Addison's disease.
Pérez de Nanclares G; Martín-Pagola A; Ramón Bilbao J; Vázquez F; Castaño L
Autoimmunity; 2004; 37(6-7):453-6. PubMed ID: 15621571
[TBL] [Abstract][Full Text] [Related]
31. Association of the A/G polymorphism at position 49 in exon 1 of CTLA-4 with the susceptibility to unexplained recurrent spontaneous abortion in the Chinese population.
Wang X; Lin Q; Ma Z; Hong Y; Zhao A; Di W; Lu P
Am J Reprod Immunol; 2005 Feb; 53(2):100-5. PubMed ID: 15790344
[TBL] [Abstract][Full Text] [Related]
32. CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese.
Rasmussen HB; Kelly MA; Francis DA; Clausen J
J Neurol Sci; 2001 Mar; 184(2):143-7. PubMed ID: 11239948
[TBL] [Abstract][Full Text] [Related]
33. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland.
Heggarty S; Suppiah V; Silversides J; O'doherty C; Droogan A; McDonnell G; Hawkins S; Graham C; Vandenbroeck K
J Neuroimmunol; 2007 Jul; 187(1-2):187-91. PubMed ID: 17524498
[TBL] [Abstract][Full Text] [Related]
34. CTLA-4 gene polymorphisms (-318C/T, +49A/G, +6230A/G) in Iranian patients with multiple sclerosis.
Heidari A; Noori Daloii MR; Keramatipour M; Rashikinezhad A; Sahmani AA; Amirzargar AA
Iran J Allergy Asthma Immunol; 2010 Dec; 9(4):219-23. PubMed ID: 21131701
[TBL] [Abstract][Full Text] [Related]
35. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism.
Vaidya B; Oakes EJ; Imrie H; Dickinson AJ; Perros P; Kendall-Taylor P; Pearce SH
Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750
[TBL] [Abstract][Full Text] [Related]
36. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
[TBL] [Abstract][Full Text] [Related]
37. The CTLA-4 gene is associated with multiple sclerosis.
Ligers A; Xu C; Saarinen S; Hillert J; Olerup O
J Neuroimmunol; 1999 Jun; 97(1-2):182-90. PubMed ID: 10408973
[TBL] [Abstract][Full Text] [Related]
38. Complex association analysis of graves disease using a set of polymorphic markers.
Chistyakov DA; Savost'anov KV; Turakulov RI; Petunina NA; Trukhina LV; Kudinova AV; Balabolkin MI; Nosikov VV
Mol Genet Metab; 2000 Jul; 70(3):214-8. PubMed ID: 10924276
[TBL] [Abstract][Full Text] [Related]
39. Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene.
Zalloua PA; Abchee A; Shbaklo H; Zreik TG; Terwedow H; Halaby G; Azar ST
Hum Immunol; 2004 Jul; 65(7):719-24. PubMed ID: 15301861
[TBL] [Abstract][Full Text] [Related]
40. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland.
Greve B; Simonenko R; Illes Z; Peterfalvi A; Hamdi N; Mycko MP; Selmaj KW; Rozsa C; Rajczy K; Bauer P; Berger K; Weissert R
Mult Scler; 2008 Mar; 14(2):153-8. PubMed ID: 17942509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
